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Abstract
Collagen has been extensively used as a biomaterial, yet for tubular organ repair,
synthetic polymers or metals (e.g., stents) are typically used. In this study, we report a
novel type of tubular implant solely consisting of type I collagen, suitable to self‐expand
in case of minimal invasive implantation. Potential benefits of this collagen scaffold
over conventional materials include improved endothelialization, biodegradation over
time, and possibilities to add bioactive components to the scaffold, such as anticoagu-
lants. Implants were prepared by compression of porous scaffolds consisting of fibrillar
type I collagen (1.0–2.0% (w/v)). By applying carbodiimide cross‐linking to the com-
pressed scaffolds in their opened position, entropy‐driven shape memory was induced.
The scaffolds were subsequently crimped and dried around a guidewire. Upon expo-
sure to water, crimped scaffolds deployed within 15–60 s (depending on the collagen
concentration used), thereby returning to the original opened form. The scaffolds were
cytocompatible as assessed by cell culture with human primary vascular endothelial and
smooth muscle cells. Compression force required to compress the open scaffolds
increased with collagen content from 16 to 32 mN for 1.0% to 2.0% (w/v) collagen
scaffolds. In conclusion, we report the first self‐expandable tubular implant consisting
of solely type I collagen that may have potential as a biological vascular implant.
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1 | INTRODUCTION
The main function of tubular structures, such as blood vessels or bile
ducts, is the transportation of fluids. These structures may become
blocked due to atherosclerotic diseases (e.g., stenoses) or malignan-
cies. Biomaterials have proven to be effective tools to ensure patency
of tubular structures. Currently, the majority of devices for clinical use
are permanent implants, mostly metals or medical textiles such as
expanded polytetrafluoroethylene. The concept of biodegradability
has gained interest over the last years as it comes with obvious
benefits. The absence of foreign body material at long‐term follow‐
up may reduce the risk of complications such as occlusion of blood
vessels and infection (Tenekecioglu et al., 2016). Currently used biode-
gradable implants for tubular tissues, often prepared from synthetic
polymers or magnesium, only play a supportive role in keeping the
structure open but do not actively facilitate re‐endothelialization.
Materials of biological origin such as type I collagen may be more
suitable as they are well known for their excellent biocompatibility
(Glowacki & Mizuno, 2008).
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
© 2018 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons Ltd.
*Luuk R.M. Versteegden and Marja ter Meer contributed equally to study
results.
Received: 6 April 2017 Revised: 25 February 2018 Accepted: 16 April 2018
DOI: 10.1002/term.2685
1494 J Tissue Eng Regen Med. 2018;12:1494–1498.wileyonlinelibrary.com/journal/term
Another important feature for tubular implants from biological ori-
gin would be the ability to self‐expand (shape memory). Biodegradable
thermally induced shape memory tubular implants prepared from
synthetic polymers have been developed, and the Igaki‐Tamai PLLA‐-
based coronary stent has been successfully evaluated in humans
(Nishio et al., 2012). However, alternatives prepared from materials
of only natural origin are lacking.
Recently, a novel method was developed to endow collagen
implants with entropy‐driven shape memory using straightforward
carbodiimide cross‐linking in combination with compression tech-
niques (Versteegden et al., 2016). The method was used to create a
star‐shaped tubular scaffold with a shape memory designed for lumi-
nal closure (Versteegden et al., 2017). In the current communication,
we report the construction of a novel tubular implant consisting of
only type I collagen, with an inverse shape memory. This scaffold
has the ability to self‐expand from a crimped state to a tubular shape,
similar to a self‐expandable stent used in vascular disease treatment.
Parameters such as deployment time, cytocompatibility, and mechan-
ical compression strength are addressed. To the best of our knowl-
edge, this is the first self‐expanding scaffold in the field of vascular
medicine that consists of solely type I collagen and which may be suit-
able for minimally invasive implantation procedures, that is, it does not
require the use of open surgery with accompanying risks of infection
(Koens et al., 2015).
Tubular collagen scaffolds with a luminal diameter of 4 and 6 mm
were prepared from insoluble fibrillar type I collagen purified from
bovine Achilles tendon by swelling the collagen (1.0%, 1.5%, and
2.0% w/v) in 0.25M acetic acid followed by a casting, molding, freez-
ing, and lyophilization process (Pieper, Oosterhof, Dijkstra, Veerkamp,
& van Kuppevelt, 1999; Versteegden et al., 2016). These tubular
scaffolds (Figure 1, Step 1) were used as the starting point for
preparation of the self‐expandable collagen scaffolds. Scaffolds were
compressed between two aluminum objects by applying pressure
under a rolling motion until the scaffold had a film‐like appearance
(Figure 1, Step 2). Next, carbodiimide cross‐linking was applied to
stabilize the construct in the tubular film‐like shape that it should have
after implantation in a blood vessel. This step is crucial in inducing
shape memory. For cross‐linking, the scaffolds were incubated in
50mM 2‐morpholineoethane sulphonic acid (MES buffer, pH 5.0,
USB, Ohio, USA) containing 40% (v/v) ethanol, 33mM N‐ethyl‐3‐(3‐
dimethylaminopropyl) carbodiimide hydrochloride (EDC, Merck
Schuchardt OHG, Hohenbrunn, Germany), and 6mM N‐
hydroxysuccinimide (NHS, Fluka Chemie AG, Buchs, Switserland),
followed by subsequent washing steps with 0.1M Na2HPO4
(2 × 1 hr), 1.0M NaCl (2 × 15 min), 2.0M NaCl (2 × 15 min), and
demineralized water (6 × 15 min) after which they were placed in
70% (v/v) ethanol (Figure 1, Step 3). Subsequently, tubular scaffolds
were placed over a metal guidewire, crimped with 500 kPa using an
automated radial compression machine (Blockwise Engineering,
Tempe, AZ, USA) and air‐dried for 15 min (Figure 1, Steps 4 + 5).
To visualize the self‐expanding property, the crimped scaffolds
with original diameters of 6 mm were placed in a plastic tube with
an internal diameter of 7 mm using a metal guide wire. Water was
pumped through the tube using a 50‐ml syringe to allow scaffolds to
expand. In this experiment, collagen scaffolds made from suspensions
containing 1.0%, 1.5%, and 2.0% (w/v) collagen were analysed. Videos
and images were recorded using a Sony HDR‐CX405 camera (Sony,
Tokyo, Japan). To show that the self‐expandability also works in the
presence of blood plasma, the 1% scaffolds were also exposed to
human blood plasma, obtained from a healthy volunteer.
FIGURE 1 Production process of the self‐expandable vascular implant. Step 1: Porous tubular collagen scaffolds with a luminal diameter of 6 mm
(or 4 mm, not shown) were used as starting point. Step 2: The scaffolds were manually compressed between two flat objects and chemically cross‐
linked with the mandrel present. Step 3: Compression and cross‐linking resulted in a collagen scaffold with a film‐like appearance. This scaffold
was used for mechanical testing. Step 4: The compressed scaffold was crimped around a metal guide wire using an automated compression
machine and air‐dried in crimped position. Step 5: The dry crimped collagen scaffold around a guide wire in crimped position that can expand upon
exposure to water. Scale bar = 6 mm
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To assess the ability of the tubular scaffolds to withstand com-
pressive force, a tensile tester (Zwick/Roell Z2.5, Ulm, Germany) was
used to apply force using a 20 mm square block as depicted in
Figure 2c. This test simulated local compression of the scaffolds, and
subsequently, the ability of the scaffolds to return to their original
diameters was observed. A strain rate of 10 mm/min was applied
until the scaffolds (6 mm diameter, 60 mm length, 1.0%, 1.5%, and
2.0% (w/v) collagen) were compressed to 50% of their original diame-
ter. A self‐expandable metal (nitinol) stent with comparable dimen-
sions was similarly compressed to make a rough comparison of
compression force between our scaffolds and existing devices.
Applied force and displacement were recorded.
Cytocompatiblity of three scaffolds (4 mm diameter, 1.0%, 1.5%,
and 2.0% (w/v) collagen) was evaluated by a cell culture experiment
with human primary endothelial cells and human smooth muscle cells
(Sciencecell, Carlsbad, CA, USA). In brief, scaffolds were cut to a length
of 1 cm, placed in 1.5‐ml Eppendorf tubes, and washed with 70% (v/v)
ethanol for disinfection. Next, scaffolds were washed extensively with
phosphate buffered saline (pH 7.4) after which 1‐ml cell suspension in
endothelial growth medium‐2 (Lonza, Basel, Switzerland) or smooth
muscle cell medium (Sciencecell, Carlsbad, CA, USA) containing
1.3 × 105 cells was added. Seeded scaffolds were cultured overnight
under rotation at 10 rpm in a 37 °C incubator. After 24 hr, scaffolds
were transferred to 6‐wells plates, cultured for 6 days, fixed with 4%
paraformaldehyde in phosphate buffered saline, and embedded in
paraffin. Sections (4 μm) were stained with haematoxylin/eosin using
fluoroshield mounting medium (Sigma, St Louis, MO, USA) and
analysed using a Leica DMLB microscope (H&E).
A self‐expandable tubular implant was developed using a simple
method based on chemical cross‐linking of collagen, combined with
compression and subsequent crimping of the scaffold. Upon exposure
to water, the scaffold instantly deployed and fixed to the tube wall,
after which the metal guide wire could be easily removed (Movie S1,
1.0% (w/v) collagen scaffold). Deployment time increased with a higher
collagen content as the 1.0% collagen scaffolds fully deployed within
15 s, followed by within 25 and 60 s for the 1.5% and 2.0% scaffolds,
respectively (Figure 2a). The 1.0% scaffolds were also tested upon
exposure to human blood plasma, where they fully expanded in 45 s.
When submerged in water, the collagen scaffolds fully expand, and
after mechanical compression in water, the scaffolds always returned to
their fully expanded state. Compression strength of the expanded
collagen scaffolds increased with increasing collagen content: 16, 29,
and 32 mN for the 1.0, 1.5, and 2.0% (w/v) scaffolds, respectively
(Figure 2c). For the 1.5 and 2.0% (w/v) construct, significantly more
FIGURE 2 Scaffold deployment and cytocompatibility and mechanical characterization. (a) The crimped tubular collagen scaffolds of 1.0, 1.5, and
2.0% (w/v) were exposed to water inside a plastic tube. All scaffolds deployed within 1 min, a higher collagen content resulted in a longer
deployment time, scale bar is 1 cm. (b) Overview of endothelial cells and smooth muscle cells seeded on 1% collagen scaffolds with enlargements.
Scale bars are 1 mm and 10 μm. (c) Schematic representation of the mechanical analysis (left) and the results depicted in a graph (right) showing
the force needed for compression of the tubes [Colour figure can be viewed at wileyonlinelibrary.com]
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force is required for 50% compression (p < .001, one‐way ANOVAwith
Bonferroni post hoc test). However, compared with the self‐expand-
able nitinol stent, the collagen scaffolds are relatively weak at this stage,
as a force of 1 Nwas required for 50% compression of the nitinol stent.
The cytocompatibility study showed that both cell types covered the
majority of the surface on which they were seeded after 6 days of
culturing (Figure 2b). H&E staining showed that endothelial cells
displayed an endothelial cell‐like morphology. Note that due to the
applied seeding procedure, both endothelial and smooth muscle cells
were present on both the luminal side and the outside of the
scaffold but did not penetrate into the interior of the scaffold as
shown by H&E (Figure 2b, zoomed views). The scaffold shown in
Figure 2 is a 1.0% (w/v) collagen scaffold that was also representative
for the 1.5% and 2.0% (w/v) as those scaffolds also showed a confluent
lining. Overall, these results indicate appropriate cytocompatibility.
The collagen‐based, tubular‐shaped implant described can be
crimped or folded to a fraction of its original size but will re‐expand
upon exposure to water or blood plasma. This makes it a suitable mate-
rial for minimally invasive implantation techniques. Vascular medicine
was chosen as an example as the use of self‐expandable devices is
common practice in patient care in the treatment of vascular injuries
in acute (e.g., vessel perforation) and semiacute (e.g., pseudoaneurysm)
situations (Jeong, 2016). Vascular stents and endografts are inserted
through endovascular sheaths and expanded on delivery, contact with
liquids can be avoided until the construct is at the correct location.
For secure positioning without displacement in a vessel with blood
flow, rapid expansion is essential and it is therefore advantageous that
the scaffold deploys in less than 1 min and presses firmly against the
vessel wall to ensure maintenance of blood flow and to minimize the
risk of migration of the device after implantation (Xue, Dai, & Li, 2010).
A common limitation of vascular implants is the lack of re‐
endothelialization, thus the inability of endothelial cells to grow onto
the implant. The observation that endothelial cells covered a large part
of the luminal surface is promising in this respect. Cells did not migrate
into the wall of the implant. This may be especially relevant for
smooth muscle cells that may impair vascular healing due to excessive
proliferation. The observation that these cells could not enter the
scaffold indicates that the collagen may provide a temporary barrier
that may help to prevent intimal hyperplasia and restenosis (Inoue
et al., 2011). In addition, the use of flexible collagen scaffolds may
circumvent a common limitation of metal vascular implants that is
the occurrence of stress fractures due to their rigidity, restricting their
use in bending points (i.e., groin or knee).
The shape‐memory principle, which is driven by newly established
hydrophobic interactions upon cross‐linking (Versteegden et al.,
2016), may not only be relevant for treatment of vascular damage,
but can also be applied for a number of other organs such as bile ducts
(Blero, Huberty, & Deviere, 2015). In combination with modern
imaging techniques, a personalized 3D‐printed mold for the collagen
scaffold may be created for any desired shape and application.
The main limitation of the current tubular‐shaped scaffolds for
both vascular and other applications is the relatively poor compression
strength. Increasing collagen content in the suspension improved the
compression strength. However, scaffold strength can only be
increased up to a certain limit using this method. Collagen content
above 2% complicates the scaffold production process because of the
high viscosity of the collagen suspension. Whether this is a problem
in vivo in the field of vascular medicine remains to be assessed: Human
veins also compress easily yet are successfully used as arterial conduits
(Wilasrusmee et al., 2017). In case of vascular implants, the stiffness of
the stent must be large enough to resist migration; therefore, these
scaffolds require fortification and optimization for in vivo use.
Additional methods to reinforce the collagen scaffold include the use
of synthetic biodegradable polymers, or (biodegradable) metal meshes.
Collagen is often applied as a biomaterial because of its
biodegradability and biocompatibility, but it has also been associated
with thrombogenicity in blood vessel applications. Gelatin (denatured
collagen), however, has been used to impregnate Dacron vascular grafts
used in clinical practice, so as to make the material less permeable. This
coating was not associated with increased thrombosis or restenosis
(Chou et al., 2017). When thrombogenicity presents as a problem, the
material can be coated with heparin to prevent blood clotting using
the same carbodiimide cross‐linking step applied in this study
(Lammers, van deWesterlo, Versteeg, van Kuppevelt, & Daamen, 2011).
In this short communication, we report the first self‐expandable
tubular implant consisting of solely type I collagen. It may allow implan-
tation using minimal invasive techniques as it deploys within 60 s and
is cytocompatible for vascular endothelial and smooth muscle cells.
The implant may have potential for use as a biological vascular implant.
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Movie S1. Example of a 1.0% (w/v) scaffold expanding upon contact
with water.
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